Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2/3 1Phase 2 1

Status

Completed 4

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 4Dermatologic 1Breast 1

Conditions

Central Nervous System Neoplasms 3Brain Neoplasms 3Glioma 2Spinal Cord Neoplasms 1Pinealoma 1Neuroma, Acoustic 1Neoplasms, Germ Cell and Embryonal 1Meningioma 1Medulloblastoma 1Glioblastoma 1Ependymoma 1Craniopharyngioma 1Astrocytoma 1

Interventions

Temozolomide 299Radiotherapy 219Bevacizumab 139Carboplatin 91Cyclophosphamide 88Etoposide 82Filgrastim 72Vincristine 69Irinotecan 69Magnetic Resonance Spectroscopy 64Cisplatin 59Radiation 58Radiosurgery 52Surgical Procedures, Operative 41Peripheral Blood Stem Cell Transplantation 40Topotecan 39Doxorubicin 39Lomustine 37Carmustine 36sargramostim 35Granulocyte Colony-Stimulating Factor 35Melphalan 34Nivolumab 32Chemotherapy, Adjuvant 32Radiotherapy, Intensity-Modulated 29Isotretinoin 29Everolimus 29Erlotinib Hydrochloride 27Thiotepa 25Vorinostat 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × tozuleristide × CNS × Clear all
NCT04743310 2025-06-13

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

Cedars-Sinai Medical Center

Phase 2 Completed
50 enrolled
CNS

Astrocytoma, Brain Neoplasms, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Neuroma, Acoustic, Pinealoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

NCT03579602 2024-06-27

Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery

Blaze Bioscience Inc.

Phase 2/3 Completed
118 enrolled 21 charts
CNS

Brain Neoplasms, Central Nervous System Neoplasms

NCT02462629 2023-02-21

Study of BLZ-100 in Pediatric Subjects With CNS Tumors

Blaze Bioscience Inc.

Phase 1 Completed
29 enrolled
CNS

Brain Neoplasms, Central Nervous System Neoplasms

NCT02234297 2016-04-06

Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery

Blaze Bioscience Inc.

Phase 1 Completed
17 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡